FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3044590804> ?p ?o ?g. }

• W3044590804 endingPage "101495" @default.
• W3044590804 startingPage "101495" @default.
• W3044590804 abstract "Hemodynamically significant patent ductus arteriosus (hsPDA) in very low birth weight (VLBW) infants is routinely treated in many countries with oral ibuprofen. This study retrospectively assessed whether the risk of cholestatic liver disease (CLD) increased due to oral ibuprofen administration in VLBW infants.A total of 122 VLBW preterm infants (26∼32 weeks, birth weight<1500g) diagnosed with patent ductus arteriosus (PDA) admitted to our neonatal intensive care unit (NICU) between September 2016 to August 2018 were included. Sixty-four infants were diagnosed with hs-PDA and received ibuprofen treatment. VLBW infants with PDA untreated with ibuprofen served as controls. Soybean oil and fat emulsions were routinely added to parenteral nutrition (PN). Once CLD was diagnosed, the fat emulsions were immediately replaced with multi-oil fat emulsion injections. To assess the independent association of treatment and duration of ibuprofen with CLD and duration of fasting and PN, binary logistic regression or multivariate linear regression analyses were conducted, adjusting for major confounders (birth weight, gestational age, Clinical Risk Index for Babies, and cholestasis-associated risk factors).The duration of PN increased due to ibuprofen treatment for 6.559 days (95% CI: 1.769, 11.349; P=0.008), and the risk of prolonged fasting (cutoff>5 days) might have increased due to ibuprofen treatment (OR: 3.043, 95% CI: 0.965, 9.594; P=0.057). Furthermore, CLD was influenced by ibuprofen treatment (OR: 6.730; 95% CI: 1.279, 35.41; P=0.024), early thrombocytopenia 7 days postnatal (OR: 6.996; 95% CI: 1.769, 27.658; P=0.004), and late onset sepsis (OR: 6.976; 95% CI: 1.561, 31.169; P=0.011). Further analysis adjusting for cholestasis-associated risk factors revealed that CLD was influenced by the duration of ibuprofen treatment (OR: 2.864; 95% CI: 1.104, 7.422; P=0.030), Platlets counts 7 days postnatal (OR: 0.971; 95% CI: 0.950, 0.994; P=0.013), and duration of antibiotics (OR: 1.134; 95% CI: 1.002, 1.282; P=0.046).This retrospective study indicated oral ibuprofen duration-dependently increased the risk of CLD in VLBW infants with PDA, and early thrombocytopenia served as the critical risk factor." @default.
• W3044590804 created "2020-07-29" @default.
• W3044590804 creator A5005876074 @default.
• W3044590804 creator A5028945158 @default.
• W3044590804 creator A5030555027 @default.
• W3044590804 creator A5050554317 @default.
• W3044590804 creator A5054594266 @default.
• W3044590804 creator A5058695677 @default.
• W3044590804 creator A5062983364 @default.
• W3044590804 creator A5065246513 @default.
• W3044590804 creator A5091048493 @default.
• W3044590804 date "2021-03-01" @default.
• W3044590804 modified "2023-09-30" @default.
• W3044590804 title "Oral ibuprofen promoted cholestatic liver disease in very low birth weight infants with patent ductus arteriosus" @default.
• W3044590804 cites W1489757392 @default.
• W3044590804 cites W1990427380 @default.
• W3044590804 cites W2001505065 @default.
• W3044590804 cites W2009596355 @default.
• W3044590804 cites W2014811565 @default.
• W3044590804 cites W2023950153 @default.
• W3044590804 cites W2031480926 @default.
• W3044590804 cites W2060727703 @default.
• W3044590804 cites W2061792424 @default.
• W3044590804 cites W2079294637 @default.
• W3044590804 cites W2080262238 @default.
• W3044590804 cites W2080425426 @default.
• W3044590804 cites W2087164773 @default.
• W3044590804 cites W2140674956 @default.
• W3044590804 cites W2149101474 @default.
• W3044590804 cites W2153760324 @default.
• W3044590804 cites W2158399530 @default.
• W3044590804 cites W2176715710 @default.
• W3044590804 cites W2295247981 @default.
• W3044590804 cites W2303748698 @default.
• W3044590804 cites W2523469177 @default.
• W3044590804 cites W2550065912 @default.
• W3044590804 cites W2586155530 @default.
• W3044590804 cites W2924664935 @default.
• W3044590804 cites W2954422885 @default.
• W3044590804 cites W2965366438 @default.
• W3044590804 cites W4376596483 @default.
• W3044590804 doi "https://doi.org/10.1016/j.clinre.2020.06.019" @default.
• W3044590804 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32723673" @default.
• W3044590804 hasPublicationYear "2021" @default.
• W3044590804 type Work @default.
• W3044590804 sameAs 3044590804 @default.
• W3044590804 citedByCount "5" @default.
• W3044590804 countsByYear W30445908042021 @default.
• W3044590804 countsByYear W30445908042022 @default.
• W3044590804 countsByYear W30445908042023 @default.
• W3044590804 crossrefType "journal-article" @default.
• W3044590804 hasAuthorship W3044590804A5005876074 @default.
• W3044590804 hasAuthorship W3044590804A5028945158 @default.
• W3044590804 hasAuthorship W3044590804A5030555027 @default.
• W3044590804 hasAuthorship W3044590804A5050554317 @default.
• W3044590804 hasAuthorship W3044590804A5054594266 @default.
• W3044590804 hasAuthorship W3044590804A5058695677 @default.
• W3044590804 hasAuthorship W3044590804A5062983364 @default.
• W3044590804 hasAuthorship W3044590804A5065246513 @default.
• W3044590804 hasAuthorship W3044590804A5091048493 @default.
• W3044590804 hasBestOaLocation W30445908041 @default.
• W3044590804 hasConcept C126322002 @default.
• W3044590804 hasConcept C187212893 @default.
• W3044590804 hasConcept C2777091541 @default.
• W3044590804 hasConcept C2778376644 @default.
• W3044590804 hasConcept C2779083892 @default.
• W3044590804 hasConcept C2779234561 @default.
• W3044590804 hasConcept C2779944601 @default.
• W3044590804 hasConcept C2781236024 @default.
• W3044590804 hasConcept C54355233 @default.
• W3044590804 hasConcept C66322754 @default.
• W3044590804 hasConcept C71924100 @default.
• W3044590804 hasConcept C77350462 @default.
• W3044590804 hasConcept C78722104 @default.
• W3044590804 hasConcept C86803240 @default.
• W3044590804 hasConcept C90924648 @default.
• W3044590804 hasConcept C98274493 @default.
• W3044590804 hasConceptScore W3044590804C126322002 @default.
• W3044590804 hasConceptScore W3044590804C187212893 @default.
• W3044590804 hasConceptScore W3044590804C2777091541 @default.
• W3044590804 hasConceptScore W3044590804C2778376644 @default.
• W3044590804 hasConceptScore W3044590804C2779083892 @default.
• W3044590804 hasConceptScore W3044590804C2779234561 @default.
• W3044590804 hasConceptScore W3044590804C2779944601 @default.
• W3044590804 hasConceptScore W3044590804C2781236024 @default.
• W3044590804 hasConceptScore W3044590804C54355233 @default.
• W3044590804 hasConceptScore W3044590804C66322754 @default.
• W3044590804 hasConceptScore W3044590804C71924100 @default.
• W3044590804 hasConceptScore W3044590804C77350462 @default.
• W3044590804 hasConceptScore W3044590804C78722104 @default.
• W3044590804 hasConceptScore W3044590804C86803240 @default.
• W3044590804 hasConceptScore W3044590804C90924648 @default.
• W3044590804 hasConceptScore W3044590804C98274493 @default.
• W3044590804 hasFunder F4320322609 @default.
• W3044590804 hasFunder F4320328344 @default.
• W3044590804 hasIssue "2" @default.
• W3044590804 hasLocation W30445908041 @default.
• W3044590804 hasLocation W30445908042 @default.

• next